Logo do repositório

Effectiveness, safety and predictors of response to vedolizumab as first- or second-line biological therapy in patients with ulcerative colitis: A real-world observational multicenter study.

Página do item simplificado
dc.contributor.authorFerreira, S.
dc.contributor.authorParra, R. Serafim
dc.contributor.authorSassaki, L. Yukie [UNESP]
dc.contributor.authorParente, J. M. Luz
dc.contributor.authorMello, M. Kurtz de
dc.contributor.authorChebli, L. Andrade
dc.contributor.authorLuporini, R. L.
dc.contributor.authorAlves Junior, A. J. Tiburcio
dc.contributor.authorNobrega, F. J. Firmino
dc.contributor.authorSilva, B. C. da
dc.contributor.authorMiranda, E. F.
dc.contributor.authorQuaresma, A. Botelho
dc.contributor.authorNicollelli, G. Mattioli
dc.contributor.authorGasparini, R. Galhardi
dc.contributor.authorDutra, R. de Medeiros [UNESP]
dc.contributor.authorSilva, K. da Conceicao da
dc.contributor.authorMagro, D. Oliveira
dc.contributor.authorImbrizi, M. R.
dc.contributor.authorNagasako, C. Kibune
dc.contributor.authorFeres, O.
dc.contributor.authorTroncon, L. E. de Almeida
dc.contributor.authorKotze, P. G.
dc.contributor.authorChebli, J. M. Fonseca
dc.contributor.institutionHosp Clin Ribeirao Preto Med Sch
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniv Fed Piaui
dc.contributor.institutionUniv Vale Itajai
dc.contributor.institutionUniv Fed Juiz de Fora
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)
dc.contributor.institutionPUC Campinas Med Sch
dc.contributor.institutionUniv Fed Paraiba
dc.contributor.institutionHosp Bahia
dc.contributor.institutionPontificia Univ Catolica Parana PUCPR
dc.contributor.institutionUniv Oeste Santa Catarina UNOESC
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)
dc.contributor.institutionSete Specialized Med Ctr
dc.contributor.institutionHosp Univ Univ Fed Piaui
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionPontificia Univ Catol Parana PUCPR
dc.date.accessioned2025-04-29T18:56:35Z
dc.date.issued2025-01-22
dc.description.affiliationHosp Clin Ribeirao Preto Med Sch, Med, Ribeirao Preto, Brazil
dc.description.affiliationHosp Clin Ribeirao Preto Med Sch, Surg & Anat, Ribeirao Preto, SP, Brazil
dc.description.affiliationSao Paulo State Univ UNESP, Med Sch, Internal Med, Botucatu, Brazil
dc.description.affiliationUniv Fed Piaui, Hlth Sci Ctr, Div Gastroenterol Med Course, Teresina, Brazil
dc.description.affiliationUniv Vale Itajai, Med, Itajai, Brazil
dc.description.affiliationUniv Fed Juiz de Fora, Div Gastroenterol, Med, Juiz De Fora, Brazil
dc.description.affiliationFed Univ Sao Carlos UFSCar, Med, Sao Carlos, Brazil
dc.description.affiliationPUC Campinas Med Sch, Surg, Campinas, Brazil
dc.description.affiliationUniv Fed Paraiba, Lauro Wanderley Hosp, Gastroenterol, Joao Pessoa, Brazil
dc.description.affiliationHosp Bahia, Gastroenterol, Salvador, Brazil
dc.description.affiliationPontificia Univ Catolica Parana PUCPR, Surgey, Curitiba, Brazil
dc.description.affiliationUniv Oeste Santa Catarina UNOESC, Surg, Joacaba, Brazil
dc.description.affiliationHosp Clin UFPR, Surg, Curitiba, Brazil
dc.description.affiliationSete Specialized Med Ctr, Marilia, Brazil
dc.description.affiliationHosp Univ Univ Fed Piaui, Med, Teresina, Brazil
dc.description.affiliationState Univ Campinas UNICAMP, Surg, Campinas, Brazil
dc.description.affiliationState Univ Campinas UNICAMP, Med, Campinas, Brazil
dc.description.affiliationUniv Sao Paulo, Ribeirao Preto Med Sch, Surg & Anat, Ribeirao Preto, Brazil
dc.description.affiliationUniv Sao Paulo, Ribeirao Preto Med Sch, Med, Ribeirao Preto, Brazil
dc.description.affiliationPontificia Univ Catol Parana PUCPR, Hlth Sci Postgrad Program, Curitiba, Brazil
dc.description.affiliationUnespSao Paulo State Univ UNESP, Med Sch, Internal Med, Botucatu, Brazil
dc.format.extenti1335-i1336
dc.identifierhttp://dx.doi.org/10.1093/ecco-jcc/jjae190.0856
dc.identifier.citationJournal Of Crohns & Colitis. Oxford: Oxford Univ Press, v. 19, p. i1335-i1336, 2025.
dc.identifier.doi10.1093/ecco-jcc/jjae190.0856
dc.identifier.issn1873-9946
dc.identifier.urihttps://hdl.handle.net/11449/300860
dc.identifier.wosWOS:001407677100020
dc.language.isoeng
dc.publisherOxford Univ Press
dc.relation.ispartofJournal Of Crohns & Colitis
dc.sourceWeb of Science
dc.titleEffectiveness, safety and predictors of response to vedolizumab as first- or second-line biological therapy in patients with ulcerative colitis: A real-world observational multicenter study.en
dc.typeResumopt
dcterms.licensehttp://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html
dcterms.rightsHolderOxford Univ Press
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos

Coleções

Botucatu - FMB - Faculdade de Medicina